Is rituximab superior to cyclophosphamide for ANCA-associated vasculitis for induction of remission, and with a better safety profile?
- PMID: 20844995
- DOI: 10.1007/s11926-010-0133-y
Is rituximab superior to cyclophosphamide for ANCA-associated vasculitis for induction of remission, and with a better safety profile?
Comment on
-
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.N Engl J Med. 2010 Jul 15;363(3):211-20. doi: 10.1056/NEJMoa0909169. N Engl J Med. 2010. PMID: 20647198 Clinical Trial.
-
Rituximab versus cyclophosphamide for ANCA-associated vasculitis.N Engl J Med. 2010 Jul 15;363(3):221-32. doi: 10.1056/NEJMoa0909905. N Engl J Med. 2010. PMID: 20647199 Free PMC article. Clinical Trial.
Similar articles
-
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.N Engl J Med. 2010 Jul 15;363(3):211-20. doi: 10.1056/NEJMoa0909169. N Engl J Med. 2010. PMID: 20647198 Clinical Trial.
-
Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.Semin Arthritis Rheum. 2015 Aug;45(1):67-9. doi: 10.1016/j.semarthrit.2015.02.005. Epub 2015 Feb 20. Semin Arthritis Rheum. 2015. PMID: 25796088 Free PMC article.
-
Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study.Arthritis Rheumatol. 2019 Jun;71(6):952-963. doi: 10.1002/art.40802. Epub 2019 Apr 16. Arthritis Rheumatol. 2019. PMID: 30666823 Free PMC article. Clinical Trial.
-
Rituximab in ANCA-Associated Vasculitis.Curr Rheumatol Rep. 2017 Feb;19(2):6. doi: 10.1007/s11926-017-0632-1. Curr Rheumatol Rep. 2017. PMID: 28155022 Review.
-
Treatment of ANCA-associated vasculitis: new therapies and a look at old entities.Adv Chronic Kidney Dis. 2014 Mar;21(2):182-93. doi: 10.1053/j.ackd.2014.01.009. Adv Chronic Kidney Dis. 2014. PMID: 24602467 Review.
Cited by
-
Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone.ISRN Neurol. 2013 Sep 10;2013:748127. doi: 10.1155/2013/748127. eCollection 2013. ISRN Neurol. 2013. PMID: 24109519 Free PMC article.
-
Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.Pharmacoeconomics. 2014 Dec;32(12):1171-83. doi: 10.1007/s40273-014-0189-z. Pharmacoeconomics. 2014. PMID: 25059204 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources